{"id":9810,"date":"2021-11-26T07:27:25","date_gmt":"2021-11-26T06:27:25","guid":{"rendered":"https:\/\/thesmartcityjournal.cibeles.net\/sin-categoria\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies\/"},"modified":"2021-11-25T20:55:54","modified_gmt":"2021-11-25T19:55:54","slug":"the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies","status":"publish","type":"post","link":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies","title":{"rendered":"The OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies"},"content":{"rendered":"

Within the project, GMV is responsible for the access, management and harmonization of the data, working according to the OMOP standard<\/em><\/p>\n

The European Union and the pharmaceutical industry, through the IMI (Innovative Medicines Initiative), have launched the OPTIMA<\/strong> project, with the ambitious goal of revolutionizing cancer treatment in Europe. OPTIMA<\/strong>‘s mission is to ensure that every patient has access to individualized treatments that take advantage of the latest technological advances.<\/p>\n

To this end, a platform will be created for broad data access and exploitation of massive data from a vast network of European hospitals. The project has a budget of 21.3 million euros and 36 European entities, leaders in the fight against cancer, participating.<\/p>\n

This platform will apply artificial intelligence mechanisms to Real-World Data (RWD), in order to answer the most important research questions in breast, prostate and lung cancer, especially those in which the current evidence is weak or not covered by medical guides. One of the key aspects is to use the technologies to access and train artificial intelligence algorithms in distributed environments, ensuring compliance with the European Data Protection Regulation (GDPR)<\/p>\n

The platform currently has 200 million records on the three types of cancer, making OPTIMA<\/strong> one of the best prepared and most ambitious initiatives in this field of research worldwide.<\/p>\n

Within the project, GMV<\/strong><\/a> is responsible for data access, management, and alignment, working in accordance with the OMOP standard, and also for the Platform design and extraction of complex information using Natural Language Processing technologies.<\/p>\n

Combining efforts and intentions<\/h2>\n

The OPTIMA<\/strong> consortium is jointly led by Professor Dr James N\u2019Dow from the European Association of Urology<\/strong> and Dr Hagen Kr\u00fcger, Medical Director of Oncology at Pfizer Germany.<\/strong><\/p>\n

As stated by Professor N\u2019Dow<\/strong>, \u201cthe primary goal of OPTIMA is to harness the potential of AI to enable healthcare professionals to provide the optimal personalized care for each patient with prostate, breast and lung cancer. This is an ambitious goal that the entire consortium is intent on achieving, taking advantage of its members\u2019 diversity of knowledge and experiences. By working together we hope to achieve significant improvements in cancer care.”<\/em><\/p>\n

Dr Kr\u00fcger,<\/strong> meanwhile, stressed that \u201calthough healthcare has begun to harness AI to improve treatment for cancer patients, there is still an immense, untapped potential to integrate these next-generation tools into models of care and decision making. We hope that OPTIMA will be a key driver in the development of personalized treatments that recognize the individual needs of each patient.\u201d<\/em><\/p>\n

Likewise, Dr Pierre Meulien, Executive Director of IMI<\/strong>, commented on OPTIMA<\/strong> that \u201cthe project brings together experts from a wide range of disciplines and organizations. So it is in a good position to deliver results that could accelerate the use of artificial intelligence in caring for people with cancer.\u201d<\/em><\/p>\n

Javier T\u00e9llez, Innovation Manager of Secure e-Solutions at GMV<\/strong> reiterated that \u201cOPTIMA is at the forefront of healthcare innovation in Europe, and GMV will apply all the experience gained from its participation in relevant healthcare research projects such as EHDEN, PIONEER or Harmony to this first one.\u201d<\/em> Specifically, \u201cour objective is to go even further than what has been achieved so far, and facilitate broad access to massive data sets in a secure way, to get the most out of Artificial Intelligence and predictive analytics tools, which has been limited until now, due to the restricted access to quality data that there has been.\u201d Something that should also be highlighted is that the OPTIMA platform \u201ccan be used for other types of cancer and the evidence generated will facilitate the implementation of efficient health policies.\u201d<\/em><\/p>\n

Members of the OPTIMA<\/strong> consortium listed in alphabetical order:<\/p>\n\n\n\n
\n

 <\/p>\n

Abbvie<\/p>\n

Amgen CH<\/p>\n

Arttic Innovation<\/p>\n

Association EISBM<\/p>\n

Bayer AG<\/p>\n

CASUS, Helmholtz-Zentrum Dresden – Rossendorf<\/p>\n

European Association of Urology<\/p>\n

European Cancer Patient Coalition<\/p>\n

European Institute of Oncology<\/p>\n

European Lung Foundation<\/p>\n

European Organization for Research and Treatment of Cancer<\/p>\n

European Respiratory Society<\/p>\n

 <\/p>\n<\/td>\n

\n

 <\/p>\n

Erasmus Universitair Medisch Centrum Rotterdam<\/p>\n

German Cancer Society<\/p>\n

GMV Soluciones Globales de Internet SAU<\/p>\n

Helios Klinikum Emil von Behring<\/p>\n

Institut de Cancerologie de l\u2019Ouest<\/p>\n

Institut Universitari d\u2019Investigacio en Atencio Primaria<\/p>\n

Information Technology for Translational Medicine<\/p>\n

Ludwig-Maximilians-University Munich<\/p>\n

Lund University<\/p>\n<\/td>\n

\n

 <\/p>\n

Oxford University<\/p>\n

Queen Mary University of London<\/p>\n

Pfizer<\/p>\n

Roche CH<\/p>\n

SmartReporting GMBH<\/p>\n

Tartu \u00dclikoo<\/p>\n

The University Court of the University of Aberdeen<\/p>\n

ttopstart<\/p>\n

University College London<\/p>\n

University of Vienna<\/p>\n

Universita Vita-Salute San Raffaele<\/p>\n

Uppsala University<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Within the project, GMV is responsible for the access, management and harmonization of the data, working according to the OMOP standard The European Union and the pharmaceutical industry, through the IMI (Innovative Medicines Initiative), have launched the OPTIMA project, with the ambitious goal of revolutionizing cancer treatment in Europe. OPTIMA’s mission is to ensure that\u2026<\/p>\n","protected":false},"author":2,"featured_media":9773,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_scj_primary_category_id":88,"_scj_featured":false,"_scj_featured_from":"","_scj_featured_until":"","_scj_featured_order":0,"_scj_visibility_class":"current","_scj_layout_family":"standard","_scj_article_style":"","_scj_display_overrides":[],"_scj_intro_image_id":9773,"_scj_intro_alt":"The OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies","_scj_intro_caption":"","_scj_intro_class":"","_scj_intro_float":"","_scj_full_image_id":9773,"_scj_full_alt":"The OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies","_scj_full_caption":"","_scj_full_class":"","_scj_full_float":"","_scj_media_type":"","_scj_media_provider":"","_scj_media_external_id":"","_scj_media_url":"","_scj_media_poster_id":0,"_scj_media_width":0,"_scj_media_height":0,"_scj_media_aspect_ratio":"","_scj_media_description":"","_scj_gallery_items":[],"_scj_related_post_ids":[],"_scj_additional_authors":[],"scj_layout_family":"standard","scj_media_provider":"","scj_media_url":"","scj_full_caption":"","footnotes":""},"categories":[88],"tags":[],"class_list":["post-9810","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-smart-health"],"yoast_head":"\nThe OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies - thesmartcityjournal.com<\/title>\n<meta name=\"description\" content=\"The European Union and the pharmaceutical industry, through the IMI (Innovative Medicines Initiative), have launched the OPTIMA project, with the ambitious goal of revolutionizing cancer treatment in Europe. OPTIMA's mission is to ensure that every patient has access to individualized treatments that take advantage of the latest technological advances.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies - thesmartcityjournal.com\" \/>\n<meta property=\"og:description\" content=\"The European Union and the pharmaceutical industry, through the IMI (Innovative Medicines Initiative), have launched the OPTIMA project, with the ambitious goal of revolutionizing cancer treatment in Europe. OPTIMA's mission is to ensure that every patient has access to individualized treatments that take advantage of the latest technological advances.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies\" \/>\n<meta property=\"og:site_name\" content=\"thesmartcityjournal.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/thesmartcityjournal\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-26T06:27:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2021\/11\/proyecto_OPTIMA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Redacci\u00f3n de The Smart City Journal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@SmartCityJour_\" \/>\n<meta name=\"twitter:site\" content=\"@SmartCityJour_\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redacci\u00f3n de The Smart City Journal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies\"},\"author\":{\"@type\":\"Organization\",\"name\":\"Redacci\u00f3n de The Smart City Journal\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/author\\\/smart-city\"},\"headline\":\"The OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies\",\"datePublished\":\"2021-11-26T06:27:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies\"},\"wordCount\":746,\"publisher\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/proyecto_OPTIMA.jpg\",\"articleSection\":[\"Smart Health\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies\",\"name\":\"The OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies - thesmartcityjournal.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/proyecto_OPTIMA.jpg\",\"datePublished\":\"2021-11-26T06:27:25+00:00\",\"description\":\"The European Union and the pharmaceutical industry, through the IMI (Innovative Medicines Initiative), have launched the OPTIMA project, with the ambitious goal of revolutionizing cancer treatment in Europe. OPTIMA's mission is to ensure that every patient has access to individualized treatments that take advantage of the latest technological advances.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies#primaryimage\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/proyecto_OPTIMA.jpg\",\"contentUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/proyecto_OPTIMA.jpg\",\"width\":1024,\"height\":576,\"caption\":\"El proyecto OPTIMA busca mejorar el tratamiento para el c\u00e1ncer de pr\u00f3stata, mama y pulm\u00f3n aplicando tecnolog\u00edas de vanguardia\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#website\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\",\"name\":\"thesmartcityjournal.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Organization\",\"NewsMediaOrganization\"],\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#organization\",\"name\":\"thesmartcityjournal.com\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo-smart-city-journal-1.png\",\"contentUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo-smart-city-journal-1.png\",\"width\":346,\"height\":91,\"caption\":\"thesmartcityjournal.com\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/thesmartcityjournal\",\"https:\\\/\\\/x.com\\\/SmartCityJour_\",\"https:\\\/\\\/www.instagram.com\\\/thesmartcityjournal_\\\/\",\"https:\\\/\\\/www.tiktok.com\\\/@thesmartcityjournal\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/the-smart-city-journal\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCIPTMzK206pVFxMNjO7SSxw\"]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#\\\/schema\\\/person\\\/39c9da1aeac1b5c2d179ef9e4e293cf4\",\"name\":\"Redacci\u00f3n de The Smart City Journal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"caption\":\"Redacci\u00f3n de The Smart City Journal\"},\"description\":\"Equipo de redacci\u00f3n de The Smart City Journal.\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/author\\\/smart-city\"},{\"@type\":\"SiteNavigationElement\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#site-navigation\",\"cssSelector\":[\".cib-main-menu\"]},{\"@type\":\"WPHeader\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#header\",\"cssSelector\":[\".cib-header\"]},{\"@type\":\"WPFooter\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#footer\",\"cssSelector\":[\".cib-footer\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies - thesmartcityjournal.com","description":"The European Union and the pharmaceutical industry, through the IMI (Innovative Medicines Initiative), have launched the OPTIMA project, with the ambitious goal of revolutionizing cancer treatment in Europe. OPTIMA's mission is to ensure that every patient has access to individualized treatments that take advantage of the latest technological advances.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies","og_locale":"en_US","og_type":"article","og_title":"The OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies - thesmartcityjournal.com","og_description":"The European Union and the pharmaceutical industry, through the IMI (Innovative Medicines Initiative), have launched the OPTIMA project, with the ambitious goal of revolutionizing cancer treatment in Europe. OPTIMA's mission is to ensure that every patient has access to individualized treatments that take advantage of the latest technological advances.","og_url":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies","og_site_name":"thesmartcityjournal.com","article_publisher":"https:\/\/www.facebook.com\/thesmartcityjournal","article_published_time":"2021-11-26T06:27:25+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2021\/11\/proyecto_OPTIMA.jpg","type":"image\/jpeg"}],"author":"Redacci\u00f3n de The Smart City Journal","twitter_card":"summary_large_image","twitter_creator":"@SmartCityJour_","twitter_site":"@SmartCityJour_","twitter_misc":{"Written by":"Redacci\u00f3n de The Smart City Journal","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies#article","isPartOf":{"@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies"},"author":{"@type":"Organization","name":"Redacci\u00f3n de The Smart City Journal","url":"https:\/\/www.thesmartcityjournal.com\/en\/author\/smart-city"},"headline":"The OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies","datePublished":"2021-11-26T06:27:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies"},"wordCount":746,"publisher":{"@id":"https:\/\/www.thesmartcityjournal.com\/en#organization"},"image":{"@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies#primaryimage"},"thumbnailUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2021\/11\/proyecto_OPTIMA.jpg","articleSection":["Smart Health"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies","url":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies","name":"The OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies - thesmartcityjournal.com","isPartOf":{"@id":"https:\/\/www.thesmartcityjournal.com\/en#website"},"primaryImageOfPage":{"@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies#primaryimage"},"image":{"@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies#primaryimage"},"thumbnailUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2021\/11\/proyecto_OPTIMA.jpg","datePublished":"2021-11-26T06:27:25+00:00","description":"The European Union and the pharmaceutical industry, through the IMI (Innovative Medicines Initiative), have launched the OPTIMA project, with the ambitious goal of revolutionizing cancer treatment in Europe. OPTIMA's mission is to ensure that every patient has access to individualized treatments that take advantage of the latest technological advances.","breadcrumb":{"@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies#primaryimage","url":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2021\/11\/proyecto_OPTIMA.jpg","contentUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2021\/11\/proyecto_OPTIMA.jpg","width":1024,"height":576,"caption":"El proyecto OPTIMA busca mejorar el tratamiento para el c\u00e1ncer de pr\u00f3stata, mama y pulm\u00f3n aplicando tecnolog\u00edas de vanguardia"},{"@type":"BreadcrumbList","@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/the-optima-project-aims-to-advance-treatments-for-prostate-breast-and-lung-cancer-by-applying-cutting-edge-technologies#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.thesmartcityjournal.com\/en"},{"@type":"ListItem","position":2,"name":"The OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies"}]},{"@type":"WebSite","@id":"https:\/\/www.thesmartcityjournal.com\/en#website","url":"https:\/\/www.thesmartcityjournal.com\/en","name":"thesmartcityjournal.com","description":"","publisher":{"@id":"https:\/\/www.thesmartcityjournal.com\/en#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.thesmartcityjournal.com\/en?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Organization","NewsMediaOrganization"],"@id":"https:\/\/www.thesmartcityjournal.com\/en#organization","name":"thesmartcityjournal.com","url":"https:\/\/www.thesmartcityjournal.com\/en","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thesmartcityjournal.com\/en#\/schema\/logo\/image\/","url":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2026\/09\/logo-smart-city-journal-1.png","contentUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2026\/09\/logo-smart-city-journal-1.png","width":346,"height":91,"caption":"thesmartcityjournal.com"},"image":{"@id":"https:\/\/www.thesmartcityjournal.com\/en#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/thesmartcityjournal","https:\/\/x.com\/SmartCityJour_","https:\/\/www.instagram.com\/thesmartcityjournal_\/","https:\/\/www.tiktok.com\/@thesmartcityjournal","https:\/\/www.linkedin.com\/company\/the-smart-city-journal\/","https:\/\/www.youtube.com\/channel\/UCIPTMzK206pVFxMNjO7SSxw"]},{"@type":"Organization","@id":"https:\/\/www.thesmartcityjournal.com\/en#\/schema\/person\/39c9da1aeac1b5c2d179ef9e4e293cf4","name":"Redacci\u00f3n de The Smart City Journal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","caption":"Redacci\u00f3n de The Smart City Journal"},"description":"Equipo de redacci\u00f3n de The Smart City Journal.","url":"https:\/\/www.thesmartcityjournal.com\/en\/author\/smart-city"},{"@type":"SiteNavigationElement","@id":"https:\/\/www.thesmartcityjournal.com\/en#site-navigation","cssSelector":[".cib-main-menu"]},{"@type":"WPHeader","@id":"https:\/\/www.thesmartcityjournal.com\/en#header","cssSelector":[".cib-header"]},{"@type":"WPFooter","@id":"https:\/\/www.thesmartcityjournal.com\/en#footer","cssSelector":[".cib-footer"]}]}},"_links":{"self":[{"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/posts\/9810","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/comments?post=9810"}],"version-history":[{"count":0,"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/posts\/9810\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/media\/9773"}],"wp:attachment":[{"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/media?parent=9810"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/categories?post=9810"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/tags?post=9810"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}